Navigate to
-
Parikh, director of medical pharmacy strategy at Prime/MRx, shares the latest on interchangeable biosimilars
Prime Article: Stories -
Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point
Prime Article: Stories -
FDA approved BiTEs: Brand name Generic name Route Target Indication First FDA indication approval date Blincyto Blinatumomab IV anti-CD19 / anti-CD3 Acute lymphocytic leukemia 12/3/2014 Columvi...
-
Based on the clinical trial, there are certain expectations for how long patients can anticipate seeing the benefits of treatment. The median duration of response was 11.6 months (95% CI, 4.4 to...
-
This decision to remove REMS comes one year after the FDA loosened REMS requirements and removed the site mandate for CAR T educational and training materials because they deemed the product label...
-
Prime Therapeutics offers innovative medication management solutions, supports patients with chronic conditions
Prime Article: Stories -
Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more
Prime Article: Stories -
Scientists have made remarkable progress in understanding the thousands of genes inside our cells and the link they may have to cancer. Researchers continue to discover patient-specific...